Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 272.91M P/E - EPS this Y 36.10% Ern Qtrly Grth -
Income -97.43M Forward P/E -2.43 EPS next Y -5.20% 50D Avg Chg -23.00%
Sales 3.09M PEG - EPS past 5Y - 200D Avg Chg -26.00%
Dividend N/A Price/Book 2.22 EPS next 5Y - 52W High Chg -59.00%
Recommedations 1.60 Quick Ratio 3.00 Shares Outstanding 55.16M 52W Low Chg 28.00%
Insider Own 1.97% ROA -35.77% Shares Float 21.36M Beta 1.83
Inst Own 94.47% ROE -118.82% Shares Shorted/Prior 4.43M/3.88M Price 4.96
Gross Margin - Profit Margin - Avg. Volume 174,832 Target Price 11.83
Oper. Margin -2,092.92% Earnings Date Mar 28 Volume 93,236 Change -5.52%
About Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Omega Therapeutics, Inc. News
04/25/24 Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04/23/24 Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
04/17/24 Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
04/09/24 Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
04/03/24 Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know
03/29/24 We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
09:25 AM Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
08:15 AM Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
03/06/24 Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
01/09/24 The 3 Best Biotech Stocks to Buy in January 2024
01/05/24 Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
01/05/24 Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
01/04/24 Why Novo Nordisk Stock Crushed the Market Today
01/04/24 Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
01/04/24 Novo Nordisk enters research partnerships with biotech firms
01/04/24 Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
01/02/24 Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/04/23 Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
11/21/23 Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
11/20/23 Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
OMGA Chatroom

User Image Jizzle14 Posted - 1 day ago

$OMGA May 7 – 11 https://finance.yahoo.com/news/omega-therapeutics-present-preclinical-data-110000591.html

User Image Jizzle14 Posted - 1 day ago

$OMGA Over the last 30 days, the consensus EPS estimate for the current year has increased 26%. What it means is that the sell-side analysts covering OMGA are majorly in agreement that the company will report better earnings than they predicted earlier.

User Image dirkfrank Posted - 1 day ago

$OMGA again lagging behind on a green biotech day.

User Image Godwinsol Posted - 1 day ago

$OMGA this one has touched its floor I believe. We should see some green forthcoming

User Image Braverabbit Posted - 1 day ago

$OMGA This looks like it may pop today or Monday. Remember the MMs always slam good stock down before great news. Any known news indicators coming up? Possible New Partnership??

User Image dirkfrank Posted - 2 days ago

$OMGA last three months 40% down.

User Image dirkfrank Posted - 2 days ago

$OMGA tough market…

User Image Pathonix Posted - 3 days ago

$OMGA The stock market isn't instant gratification. I'm happy with my position. I've added and continue when I am able.

User Image Danny23 Posted - 3 days ago

$OMGA Whats up with the price decline? Any thoughts?

User Image dirkfrank Posted - 3 days ago

$OMGA

User Image dirkfrank Posted - 4 days ago

$OMGA why didn’t it lift with the biotech upswing yesterday?

User Image Pathonix Posted - 4 days ago

$OMGA STRONG BUY https://ragingbiotechbuzz.blogspot.com/2024/01/omega-therapeutics-poised-for-potential.html

User Image johnnyutah007 Posted - 4 days ago

$OMGA 👀

User Image AceAri Posted - 4 days ago

$OMGA https://finance.yahoo.com/news/omega-therapeutics-present-preclinical-data-110000591.html

User Image Stock_Titan Posted - 4 days ago

$OMGA Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting https://www.stocktitan.net/news/OMGA/omega-therapeutics-to-present-new-preclinical-data-on-epigenomic-qga992d6rjxd.html

User Image johnnyutah007 Posted - 1 week ago

$OMGA 👍

User Image johnnyutah007 Posted - 1 week ago

$OMGA stupid cheap here

User Image Braverabbit Posted - 1 week ago

$OMGA I'm a new Investor to Omega and happy to be here. 😊 I've had OMGA on my ticker for 2 months. I got in a bit high (at this point) at 2.90 but am Not worried.

User Image Pathonix Posted - 1 week ago

$OMGA Institutional investors have been actively adjusting their positions in Omega Therapeutics. Tower Research Capital LLC TRC increased its stake by 72.0%, now owning 8,963 shares worth $49,000. State Street Corp boosted its position by 8.2%, now holding 55,730 shares valued at $336,000. California State Teachers Retirement System lifted its stake by 137.2%, now with 9,475 shares worth $59,000. Cubist Systematic Strategies LLC increased its holdings by 167.6%, now owning 10,007 shares valued at $60,000. Finally, Bank of America Corp DE raised its position by 72.0%, now holding 16,208 shares worth $101,000. In total, hedge funds and institutional investors own 97.47% of Omega Therapeutics' stock.

User Image Pathonix Posted - 1 week ago

$OMGA There's a reason there is a supply deal with Roche for their asset. There is also a reason Novo invested. Undervalued - bought more yesterday.

User Image zeta001 Posted - 1 week ago

$OMGA CFO leaving after a restructuring, when the company is desperate for additional investment or acquisitions, is a classic tech tree of a dying company.

User Image valueforme Posted - 1 week ago

$OMGA CFO departure with ability to exercise options for more than one year from now. Well, this is damn generous. The dude has at least half a million of options in $2.27 - $6.46 range.

User Image DonCorleone77 Posted - 1 week ago

$OMGA Omega Therapeutics CFO Joshua Reed to depart On April 10, 2024, Omega Therapeutics and Joshua Reed, the company's CFO, agreed to terminate his employment effective as of May 31, 2024. In connection with the termination, Mr. Reed will be entitled to receive the severance payments and benefits set forth in his employment agreement with the Company and extended exercisability of his exercisable Company stock options until the first anniversary of the Effective Date, in each case, subject to his entering into a separation agreement containing a release of claims. On April 16, 2024, the Board of Directors of the Company designated Barbara Chan, the Company's Senior Vice President, Finance, as its principal financial officer and principal accounting officer, in each case effective on the Effective Date.

User Image rezin8 Posted - 1 week ago

$OMGA hit 2.26 pretty close but not filled. Would nibble here but could go lower

User Image AceAri Posted - 1 week ago

$OMGA this price is truly insane. Bought more.

User Image mpap_ Posted - 1 week ago

$OMGA Bought 1k shares @ 2.28

User Image RallyRaider Posted - 1 week ago

$OMGA deranged and ridiculous. Is 40cts below announcement of NVO partnership.. LOOOTS of biobucks. Rest assured, there were many bidders. bought 2k shares

User Image Pathonix Posted - 1 week ago

$OMGA Looks like I will be adding shares once again. Shake the 🌴 tree long and hard then up OMGA will go

User Image zeta001 Posted - 1 week ago

$OMGA It's a quick trip to the all-time looooow

User Image dirkfrank Posted - 1 week ago

$OMGA another day red?

Analyst Ratings
Piper Sandler Overweight Apr 3, 24
Chardan Capital Buy Apr 1, 24
Wedbush Outperform Jan 4, 24
HC Wainwright & Co. Buy Nov 13, 23
Wedbush Outperform Nov 10, 23
HC Wainwright & Co. Buy Sep 1, 23
Chardan Capital Buy Aug 4, 23
HC Wainwright & Co. Buy Jun 6, 23
Chardan Capital Buy May 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Flagship Pioneering Inc. 10% Owner 10% Owner Feb 27 Buy 5.78 3,323,310 19,208,732 1,329,324 02/27/23
Young Richard A Director Director Sep 14 Sell 8.00 10,000 80,000 784,118 09/15/22